ADM Tronics Unlimited, Inc. announced that Aveta.Life Inc, will receive regulatory development guidance and oversight provided by ADMT. The collaboration between Aveta.Life and ADMT will ensure that the development path for the Hormonometer system will meet regulatory requirements for US FDA, CE certifications for the European Union and other regulatory specifications. At a recent meeting convened at ADM Tronics' FDA-Registered facility in Northvale, NJ, Aveta.Life launched the regulatory pathway requirements for development activities being undertaken by Aveta.Life researchers and scientists.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1048 USD | +2.24% | -9.34% | +0.29% |
1st Jan change | Capi. | |
---|---|---|
+0.29% | 6.93M | |
+9.50% | 221B | |
+7.95% | 184B | |
+18.30% | 142B | |
+18.47% | 101B | |
+7.83% | 68.07B | |
+25.32% | 57.27B | |
-3.69% | 47.42B | |
+4.66% | 43.19B | |
+15.12% | 28.84B |
- Stock
- Equities
- Stock ADM Tronics Unlimited, Inc. - OTC Markets
- News ADM Tronics Unlimited, Inc.
- ADM Tronics Unlimited, Inc. Announces Aveta.Life Inc Will Receive Regulatory Development Guidance and Oversight Provided by ADMT